Psychedelic Stocks,Shroom News Filament Health Corp Submits its 20th Patent Application By Dennis Mutua September 03, 2021 Exclusively natural psychedelics drug discovery and extraction technology company Filament Health Corp. (NEO: FH) announced having submitted its 20th patent application in support of it research phase programs. This latest pate...
Shroom News,Spotlight Stock Red Light Holland Completes Largest Legal Sale and Import of Psilocybe Truffles into Canada By Dennis Mutua September 02, 2021 Psychedelics company focused on production and sale of magical truffles Red Light Holland Corp. (CSE: TRIP) (OTCMKTS: TRUFF) announced having completed Canada’s largest legal sale and import of psilocybe truffles under a psilocy...
Psychedelic Stocks,Shroom News Australia to Use its First Magic Mushroom for Medical Treatment By Dennis Mutua September 01, 2021 Researchers from Australia based University of Queensland have been granted approval to collect psilocybin mushrooms which will help in identifying properties which might be helpful for psychedelics treatments. The federal gove...
Psychedelic Stocks,Shroom News PharmaDrug Appoints David Kideckel to Company’s Board By Dennis Mutua August 31, 2021 Pharmaceutical company specializing on research, development and commercialization of controlled substances and natural medicines like psychedelics PharmaDrug Inc. (CSE: PHRX) (OTCMKTS: LMLLF) has appointed David Kideckel to the c...
Psychedelic Stocks,Shroom News Small Pharma Appoints Lyne Fortin Non-Executive Chair of Board By Dennis Mutua August 30, 2021 Neuropharmaceutical company focusing on novel development of novel rapid-acting treatments for mental conditions like depression Small Pharma Inc. (TSXV: DMT) announced having appointed Ms. Lyne Fortin as a non-executive independe...
Shroom News,Spotlight Stock MYND Life Sciences Issues $3 Million Convertible Debenture Units By Dennis Mutua August 27, 2021 Life sciences company focused on advancing medicines that leverage on psychedelic compounds to improve mental health MYND Life Sciences (CSE: MYND) (OTCMKTS: MYNDF) announced having entered into a binding term sheet concerning a n...
Shroom News,Spotlight Stock Tryp Therapeutics Wraps Up Psychotherapy Training for Phase 2a clinical Trial By Dennis Mutua August 26, 2021 Pharmaceutical company specializing in identifying and developing clinical-stage compounds for orphan diseases and other diseases with unmet needs Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announced having completed psycho...
Psychedelic Stocks,Shroom News Beckley Raises $80 Million in Latest Series B Funding Round By Dennis Mutua August 24, 2021 Private startup company focused on helping patients suffering from neurological and psychiatric disorders by developing psychedelics medicines Beckley Psytech announced having raised $80 million from its recently concluded Series ...
